To identify bacterial predictors of recurrence and/or persistence in acute cystitis, extended virulence genotypes were compared with clonal background and epidemiologic status among 74 Escherichia coli urine isolates from women with first or recurrent episodes of urinary tract infection (UTI). Sequential isolates from patients with recurrent UTI were classified, using macrorestriction analysis, as having caused an isolated recurrence versus a single or multiple same-strain recurrences. papA, papG allele II, iha, and iutA predicted multiple same-strain recurrences, whereas nfaE and the absence of sfaS or fyuA predicted isolated recurrences. Phylogenetic group B2 accounted for 70% of isolates and for most of the putative virulence factors (VFs) studied. The meningitis-associated O18:K1:H7 clonal group comprised 18% of isolates, exhibited multiple VFs, and caused "once-only" recurrences less commonly than did other strains. These findings identify specific VFs and clonal groups against which preventive interventions might be beneficial and illustrate the importance of delineating pathogenetically relevant subgroups within the "recurrent cystitis" population. A substantial proportion of women who have an initial UTI episode experience frequent recurrences, the basis for which is understood incompletely [5, 6] . Certain behavioral or endogenous characteristics can predispose to UTI, including sexual intercourse (particularly with the use of spermicide-diaphragm contraception) [7, 8] coli strains that cause cystitis in women with a history of recurrent UTI possess traits (i.e., virulence factors [VFs]) that facilitate recurrence or persistence or, instead, are less virulent and rely on the host's underlying predisposition to UTI (e.g., a local immune defect) is unclear. In one study, among otherwise healthy women, certain characteristics of first-episode UTI isolates (i.e., the presence of afa/dra [afimbrial and fimbrial Drbinding adhesins] and the absence of cnf1 [cytotoxic necrotizing factor] and sfa/foc [S and F1C fimbriae]) predicted the occurrence of a second cystitis episode within 6 months [16] . In contrast, 2 other studies found that isolates from women with an established history of recurrent UTI differed minimally overall, compared with first-episode UTI isolates [17, 18] .
should be those able to cause 2 recurrent UTI episodes (i.e., a single same-strain recurrence). The least virulent strains should be those able to cause only a single UTI episode, despite the host's seeming predisposition to UTI, as evidenced by the history of frequent recurrences. Strains that cause a first UTI episode in a host with no prior UTI history presumably should represent a mixture of these 3 categories; hence, in the aggregate, they would exhibit an intermediate level of virulence.
The availability of an epidemiologically well-characterized collection of 74 E. coli isolates from women with a first episode of UTI or recurrent UTI [17, 19] allowed us to test a series of specific hypotheses based on the above assumptions: specifically, we hypothesized that multiple same-strain recurrence isolates would exhibit a greater overall prevalence of VFs, and we inferred that any VFs (or phylogenetic groups) specifically associated with this cohort reflect high virulence. We hypothesized that the "single same-strain" recurrence group would exhibit an intermediate prevalence of VFs overall and would not be associated with specific VFs or phylogenetic groups. We hypothesized that "once-only" recurrence isolates would have a lower overall prevalence of VFs and that any VFs (or phylogenetic groups) specifically associated with this cohort reflect reduced virulence. Finally, we hypothesized that strains causing a first UTI episode in the aggregate would exhibit an intermediate prevalence of VFs and no VF-specific associations.
To test these hypotheses, we used newly developed broadrange virulence genotyping assays [20, 21] and amplificationbased phylotyping methods [22, 23] , to further characterize the 74 urine isolates [18] . Then we evaluated the distribution of bacterial traits among relevant epidemiologically and macrorestriction-derived subgroups within the population.
Methods
Strains. Seventy-four previously described E. coli urine isolates from women with a first or recurrent episode of cystitis were analyzed [17] . These strains have been characterized, with respect to PFGE type, mannose-resistant hemagglutination and hemolysin phenotypes, O:H serotype, and genotype for papEFG and the 3 papG alleles [17] [18] [19] . The E. coli reference (ECOR) collection [24] was obtained from Howard Ochman (University of Arizona, Tucson) and the American Type Culture Collection. Pyelonephritis isolate J96 (O4:K-:H5) [25] was provided by Barbara Minshew (retired; formerly University of Washington, Seattle). Pyelonephritis isolate 536 [26] was provided by Gabriele Blum-Oehler (Universität Wü rzburg, Wü rzburg, Germany). Calvin Kunin (Ohio State University, Columbus) provided O18:K1:H7 cystitis isolates [27, 28] . Neonatal meningitis isolates RS218 and 89-1449 (O18:K1: H7) [28] were provided by Kwang Sik Kim (Johns Hopkins University, Baltimore) and Lodewijk Spanjaard (Academic Medical Center, Amsterdam), respectively. Strains were stored in 20% glycerol at Ϫ70ЊC until use.
Virulence genotypes. Strains were tested for 27 different putative VF genes of extraintestinal pathogenic E. coli (ExPEC) [29] , using dot-blot hybridization under stringent conditions, as described elsewhere [20, 22, 30] . Probes were generated and digoxigenin-labeled by using primers, as described elsewhere [20, 22, 30] . Adhesin genes included papAH, papG, sfa/focDE, focG (F1C fimbrial adhesin), iha (iron-regulated gene homologue adhesin) [30] , afa/draBC, bmaE (M fimbriae), gafD (G fimbriae), and nfaE (nonfimbrial adhesin) [31] . Siderophores included iutA (aerobactin receptor), fyuA (yersiniabactin receptor), and iroN (a novel putative siderophore) [30] . Toxins included hlyA (hemolysin), cnf1, and cdtB (cytolethal distending toxin). Capsule genes included kpsMT-II and kpsMT-III (group II and III capsule synthesis). Miscellaneous VFs included rfc (O4 lipopolysaccharide synthesis), cvaC (colicin V), traT (serum resistance), ibeA (invasion of brain epithelium), and malX, a marker for a pathogenicity-associated island (PAI) from archetypal uropathogenic strain CFT073 [20, 32] . We tested for 4 VFs, including kpsMT-K1 (K1 capsule synthesis), kpsMT-II, afa/draBC, and sfaS (S fimbrial adhesin), by polymerase chain reaction (PCR) analysis, as described elsewhere [20] . Strains that were positive by probe but negative by PCR analysis for kpsMT-II were defined as K2 capsule-positive, as described elsewhere [20] . The aggregate VF score was the total number of VFs for which an isolate was positive, with proportional adjustment made for the multiple genes that were detected within the pap and sfa/foc operons.
Strains that were positive for any pap element were tested for 12 traditional alleles of papA plus a recently discovered papA variant (F48) by using a multiplex PCR-based assay, as described elsewhere [21] . All virulence genotypes were determined at least in duplicate, using boiled lysates prepared from 2 separate colonies of each strain. Discrepant results were investigated further, with additional determinations as needed.
Phylogenetic comparison with the ECOR collection. The 74 cystitis isolates were categorized as to phylogenetic group, on the basis of randomly amplified polymorphic DNA (RAPD) analysis [23, 33] . Genomic patterns were generated in duplicate for each strain, using 2 primers (1281, 5 -AACGCGCAAC-3 , and 1283 5 -GCGATCCCCA-3 ) [23] , to give a total of 4 genomic patterns per strain. Amplification conditions were as described by Berg et al. [33] . Patterns were combined in series to create a virtual composite pattern for each strain [22, 28, 34, 35] . Genomic patterns were generated in parallel for 10 control strains from the ECOR collection (i.e., 2 from each of the 5 major phylogenetic groups, as defined by Herzer, et al. [36] , on the basis of allozymes at 38 loci). A similarity analysis was done on the basis of Pearson correlation coefficient values, as generated for comparisons of each cystitis isolate to each of 10 ECOR control strains [28, 34] . Any isolate with discrepant replicate determinations as to which ECOR strain it most closely matched underwent a third round of composite RAPD analysis. As an internal control, the ECOR strains were assessed for similarity to the other ECOR strains from the same phylogenetic group.
Serotypes. O:H serotypes were previously determined by the E. coli Reference Center (University Park, Pennsylvania) [18] . Thirteen isolates were defined as representing the O18:K1 clonal group. Of them, 11 were O18:K1, whereas 2 were O undetermined:K1 or O rough:K1, and, in the RAPD dendrogram, were placed within the cluster that contained predominantly O18:K1 strains. The six O6 isolates that were placed within the cluster that contained the 4 O6;F48 strains were defined as representing the O6;F48 clonal group.
Nicotinamide auxotrophy. Putative O18:K1 isolates were tested for growth at 30ЊC and 39ЊC on minimal media agar with and without supplementation with nicotinamide, as described elsewhere [27, 28, 37] . Strain J96 was used as a negative control, and strains RS218 and 89-1449 were used as positive controls for the outer membrane protein pattern (OMP) 6 and OMP 9 subclones, respectively, of E. coli O18:K1:H7. These strains exhibit distinctive nicotinamide auxotrophy phenotypes: that of the subclone OMP 6 is temperature independent (i.e., present at both temperatures), and that of the subclone OMP 9 is temperature dependent (i.e., present only at 39ЊC) [28, 37] .
PFGE analysis. PFGE analysis was used previously to analyze 70 isolates recovered during prospective follow-up from the 24 patients with recurrent UTI [19] . These 70 isolates represented one acute UTI episode each for 3 patients (3 isolates total) and multiple UTI episodes (2-6 each) for 21 patients (67 isolates total). The 40 unique genotypes that were resolved by PFGE constituted the recurrent UTI strain population. Of these 40 genotypes, 3 were identified as having caused у4 cystitis episodes in an individual patient; hence, they were defined as "multiple same-strain" recurrence isolates. These strains included R37 (O75:H7), R45 (O4:H5), and R55 (O118:H-undetermined). Fourteen of the genotypes were recovered only twice from a given patient; hence, they were defined as "single same-strain" recurrence isolates. The remaining 23 genotypes from patients with recurrent UTI were recovered only once each; hence, they were defined as "once-only" recurrence isolates.
Statistical methods.
Comparisons of proportions between groups were tested by using Fisher's exact test, and comparisons of proportions within the same population were tested by using McNemar's test [38] . Correlations between traits were assessed by using Cramer's F, and comparisons between groups with respect to aggregate VF scores were tested by using the Mann-Whitney U test (2-tailed). Stepwise multivariate logistic regression analysis was used to identify VFs that were independently predictive of specific epidemiologic subgroups. The threshold for statistical significance was , with considered to reflect borderline statistical P ! .01 P ! .05 significance.
Results

Epidemiologic distribution of VFs.
In the population as a whole, the various VFs ranged in prevalence from 1% (cdtB and the K2 kpsMT II variant) to 94% (fyuA; table 1), with aggregate VF scores of 0-12 (median, 5.5). With respect to individual VFs, the multiple same-strain recurrence subgroup exhibited the highest prevalence for more VFs than did any other subgroup (13 vs. 3-9 VFs; , McNemar's test, for P ! .05 multiple same-strain vs. once-only recurrence isolates). Conversely, the once-only recurrent UTI subgroup exhibited the lowest prevalence for more individual VFs than did any other subgroup (13 vs. 1-7 VFs; , McNemar's test, for once-P ! .01 only vs. either single same-strain recurrence or first-episode isolates). Aggregate VF scores were highest among the multiple same-strain recurrence isolates (median, 10), were intermediate among the 14 single same-strain recurrence and the 34 firstepisode isolates (median, 7.5 and 5.5, respectively), and were lowest among the 23 once-only recurrence isolates (median, 4).
For individual VFs, the 3 multiple same-strain recurrence isolates (compared with all other isolates) exhibited a significantly higher prevalence of papA, papG allele II, iha, and iutA, whereas the 23 once-only recurrence isolates exhibited a significantly lower prevalence of sfaS and fyuA and a significantly higher prevalence of nfaE (table 1) . In contrast, the remaining 2 subgroups either did not differ significantly from other strains with respect to any VF (single same-strain recurrence subgroup) or differed weakly only with respect to focG and fyuA (firstepisode subgroup; table 1).
Associations between VFs. Because various VFs were highly correlated with one another in an overlapping fashion (figure 1), stepwise multivariate logistic regression analysis was used to assess the independent associations of individual VFs with the extreme high-and low-virulence epidemiologic subgroups. This confirmed the presence of papG allele II, iha, and papA as independent predictors of multiple same-strain recurrence status and confirmed both the absence of sfaS and the presence of nfaE as independent predictors of once-only recurrence status (data not shown).
Phylogenetic relationships. According to composite RAPD analysis, the population consisted of 2 major phylogenetic clusters (clusters 1 and 2) comprising 52 (70%) and 22 (30%), respectively, of the isolates (figure 2). The distribution of the ECOR control strains revealed that cluster 1 corresponded mainly with ECOR phylogenetic group B2, whereas cluster 2 corresponded mainly with ECOR phylogenetic groups A, B1, and nonaligned strains. The group D ECOR strains were divided between clusters 1 (ECOR 39) and 2 (ECOR 48; figure 2 ).
The first-episode and the (aggregate) recurrent UTI isolates did not differ appreciably with respect to their distribution between cluster 1 (which included 68% and 73%, respectively, of each group) and cluster 2. All 3 multiple same-strain recurrence isolates were from cluster 1, however, and the 17 same-strain recurrence isolates were somewhat more likely to be from cluster 1 (14 Phylogenetic distribution of VFs. Clusters 1 and 2 differed dramatically with respect to the prevalence of most of the VFs assessed (table 2) . Each VF that exhibited a significant prevalence difference between clusters was more prevalent in cluster 1 than in cluster 2. VFs that exhibited the opposite trend (i.e., those somewhat more prevalent within cluster 2) included nfaE and cvaC, whereas iutA and gafD were similarly prevalent in the 2 clusters (table 2) . Aggregate VF scores were much greater within cluster 1 than cluster 2 (median, 8.5 vs. 2;
). P ! .001 Within cluster 1, 2 prominent subclusters were evident at about the 80% similarity level (figure 2). One of these clusters (clone A) comprised 6 O6 isolates (8% of the total). The other cluster (clone B) comprised 13 putative O18:K1 isolates (18% ). P p .05
Discussion
In the present study we defined extended virulence genotypes and phylogenetic relationships among urine isolates from Only those VFs that exhibited у1 correlation with another VF at the P ! level are shown. Significance levels: Ϫ, ;ϩ, ; and ϩϩ, . Parentheses indicate negative associations. cnf1, Cytotoxic .01 P 1 .01 P р .01 P р .001 necrotizing factor; cvaC, colicin V; F10 and F48, 2 papA (structural subunit) alleles; focG, F1C adhesin; fyuA, yersiniabactin receptor; gafD, G fimbriae; hlyA, hemolysin; ibeA, invasion of brain endothelium; iha, novel putative siderophore-adhesin; iroN, putative siderophore; iutA, aerobactin receptor; kpsMT, capsule synthesis (group II, group III, K1 variant, or K2 variant); malX, pathogenicity-associated island marker; nfaE, nonfimbrial adhesin; pap, P fimbriae; papG, P adhesin gene (including alleles II and III); rfc, O4 lipopolysaccharide synthesis; sfa/focDE, S and F1C fimbriae; sfaS, S fimbrial adhesin; traT, serum-resistance-associated gene.
women with a first episode of cystitis or recurrent cystitis. We found that differences between clinical groups were more numerous and more extreme when the recurrent UTI isolates were stratified by PFGE analysis according to whether they had caused any or multiple same-strain recurrent UTI episodes (as opposed to when they were analyzed collectively as a homogenous population).
Our findings illustrate the importance in epidemiologic studies of stratifying recurrent UTI isolates according to their samestrain or non-same-strain status [19, 39, 40] . The observed distribution of VFs mainly conformed to our inferred virulence strata, for which future experimental validation would be desirable. VFs were most prevalent among the multiple samestrain recurrence isolates, were least prevalent among the onceonly recurrence isolates, and were of intermediate prevalence among the single same-strain recurrence isolates and the firstepisode isolates (which presumably represent a mixture of the previous 3 groups).
VFs specifically associated with multiple same-strain recurrences (i.e., putative high-virulence VFs) included papA, papG allele II, iha, and iutA. In contrast, the association of nfaE with once-only recurrences implicated this adhesin as a putative lowvirulence VF, whereas the negative associations of sfaS and fyuA with this subgroup identified these VFs as also representing high-virulence VFs. It may be that the high-virulence VFs identified in the present study, which are adhesins and siderophores, would be good targets for interventions designed to prevent either first episodes of UTI or multiple same-strain recurrences [8, [41] [42] [43] . In addition, typing of isolates from women with recurrent UTI for these genes might allow for some prediction as to whether multiple same-strain recurrences can be expected and whether host factors (e.g., defective local immunity or increased receptivity to bacterial attachment) versus bacterial factors are more important contributors to recurrence. This, in turn, might guide decisions regarding intensity or duration of antimicrobial therapy [39, 44] , attention to potentially Dendrogram is based on similarity relationships, according to composite genomic patterns from 2 rounds (A and B) of amplification with RAPD primers 1281 and 1283, with cluster analysis according to the unweighted pair group method with averaging. Gel tracks are computer reconstructions and, hence, underestimate the resolution of the original gel images. Major clusters 1 and 2 correspond with ECOR groups B2 vs. groups A, B1, and nonaligned strains, respectively. Group D strains are divided between the 2 clusters. Within cluster 1, brackets labeled "O6" and "O18" demarcate clonal groups A and B, respectively. ECOR strains are identified parenthetically as to phylogenetic group of origin. reversible host factors [7, 13] , genomic typing of serial isolates [19] , or investigation for persisting internal or external reservoirs of such strains [19, 45, 46] . In a previous epidemiologic study that analyzed 9 VFs as predictors of recurrent UTI within 6 months of an initial UTI episode in otherwise healthy women, the only significant predictor was afa/dra (relative risk [RR], 2.3) [16] . In contrast, 3 VFs were associated significantly with absence of recurrence, including cnf (RR, 0.0), hly (RR, 0.1), and sfa/foc (RR, 0.25) [16] . All 4 recurrence episodes associated with afa/dra were same-strain recurrences. In that study, afa/dra was moderately prevalent in the population (14%), sfa/foc positivity was not further stratified as to sfa versus foc, and all patients were enrolled at the time of their first UTI episode [16] . In contrast, in the present study, afa/dra was uncommon (4%) and was not associated with recurrent UTI (whether same-strain or not); sfaS and focG, which were separately detected, exhibited opposing epidemiologic associations; single and multiple samestrain recurrences were differentiated from once-only recurrences; and isolates from patients with a history of multiple previous recurrences constituted 55% of the study population. Whether differences in study design, laboratory methods, and/ or geographic locale account for the discrepant findings of these 2 studies is unknown.
Of note, NfaE-I shares 96% peptide homology with Dr-II, which, like other members of the AFA/Dra adhesin family, mediates adherence to tubular basement membranes and Bowman's capsule and promotes bacterial internalization into HeLa cells [47] . Internalization into host cells might be expected to confer same-strain recurrence capability [48] , which would be consistent with the association of afa/dra with same-strain recurrence, as noted by Foxman et al. [16] . However, in the present study, nfaE actually was negatively associated with same-strain recurrence. This suggests that, despite their peptide homology, the NfaE-I and Dr-II adhesins may exhibit important functional differences and/or that the relationship between adhesin-mediated bacterial internalization into host cells and same-strain recurrent UTI is not straightforward. Also of note is the demonstrated in vitro ability of Dr adhesins to mediate bacterial adherence to neutrophils without triggering phagocytosis or killing [49] . Whether less favorable interactions with neutrophils could contribute to the seeming "anti-VF" associations observed with nfaE in the present study warrants investigation.
Another relevant previous study involved urine isolates from children treated for acute cystitis [39] . In that population, although papG allele II was the most prevalent papG allele and was associated with recurrence per se, papG allele III was significantly associated specifically with same-strain recurrence [39] . In contrast, in the present study, papG allele III was the most prevalent papG allele, and papG allele II was significantly associated with multiple same-strain recurrences. Differences between these 2 studies with respect to study design (treatment trial vs. observational study), host population (children with acute cystitis vs. women with first or recurrent episodes of UTI), and geographic locale (Cleveland vs. Seattle) provide several possible explanations for their discrepant findings with respect to which VFs predict recurrent UTI and, specifically, samestrain recurrence in patients with cystitis.
A noteworthy finding of the present study was that 2 large, VF-rich clonal groups accounted for 26% of the study population, a relatively large proportion, considering the tremendous diversity of E. coli clones [50] [51] [52] . The clonal group characterized by the O6 antigen and the F48 papA allele (clonal group A), which accounted for 8% of the population, also is prominent among canine UTI isolates [22, 53] , in canine feces [54] , and among human bacteremia isolates [20] (J. R. Johnson, J. Maslow, and T. T. O'Bryan, unpublished data). It corresponds with clonal group 2 of Cherifi et al. [55] , which comprised extraintestinal isolates from humans and diverse animals, and includes archetypal pyelonephritis isolate 536 (O6:K15:H31) [26, 53] , as confirmed for isolates from the present study by direct RAPD analysis in comparison with strain 536 (data not shown).
The O18:K1 clonal group (clonal group B), which accounted for 18% of the present study population, exhibited enhanced virulence in that its members were more likely than other isolates to have caused first episodes of UTI or a same-strain recurrence and were less likely to have caused once-only recurrence. By serotype and VF profile, these strains appeared to be highly similar to the O18:K1:H7 strains that Kunin et al. [27] isolated from the urine of 15% of women with cystitis in Columbus, Ohio, and to archetypal neonatal meningitis isolates RS218 and C5 [28, 56] . The suspected similarities were confirmed directly by RAPD analysis, which showed selected representatives of clonal group B to be indistinguishable from representatives of these comparison E. coli O18:K1:H7 populations (data not shown). In addition, all the members of clone B (O18:K1) exhibited nicotinamide auxotrophy at both 30ЊC and 39ЊC, which is consistent with membership in the OMP 6 rather than the OMP 9 subclone of E. coli O18:K1:H7 [28, 37] . Together with previous data regarding the Kunin cystitis isolates [28] , these findings suggest that the OMP 6 subclone of E. coli O18:K1:H7, which accounts for almost all O18:K1 neonatal meningitis isolates in the United States [37, 57] , also is a major contributor to cystitis in North American women.
Our findings of extensive associations among VFs are consistent with previous observations regarding many of the specific correlations identified here [20, 30, 58] , which thus appear to represent general trends among ExPEC. As noted elsewhere [30] , some traits that are known to be genetically linked in an index strain (such as iha and the PAI marker malX, which occur within 2 kb of one another on a PAI in archetypal strain CFT073 [59] ) may not be statistically associated with one another at the population level and may even exhibit divergent associations with other VFs [30] . This provides additional evidence that PAIs undergo remodeling and that linkages between VFs are not fixed [30, 58] .
We used a novel approach to assess linkages between VFs by analyzing the total number of different VFs associated with each individual VF. We found that, unlike other VFs, nfaE [31] , which appeared epidemiologically to be a low-virulence VF because of its positive association with the once-only recurrence subgroup, was associated with a slight decrease in aggregate VF scores (data not shown), which might contribute to its seemingly low-virulence behavior.
In contrast, although several of the putative high-virulence VFs were associated with significantly increased aggregate VF scores, these effects were not large, compared with the effects observed with other VFs that were not epidemiologically associated with virulence. Indeed, for 2 of the putative high-virulence VFs (iha and iutA), VF scores were not affected at all by the presence or absence of the trait (data not shown). Thus, although some of the enhanced virulence associated with sfaS, papA, papG allele II, and fyuA might be attributable to these VFs serving as markers for a more robust VF repertoire in general, with iha and iutA in particular, enhanced virulence could not be ascribed simply to an increased number of VFs. This strengthens the case for iha and iutA themselves and, from the multivariate analysis, for iha in particular, as direct agents of enhanced virulence. Confirmation of these findings in a larger population of multiple same-strain recurrence isolates and experimental validation of these epidemiologically derived predictions are needed.
In summary, we found through a combined molecular and phylogenetic analysis of E. coli isolates from women with firstepisode and recurrent UTI that certain putative VFs (papA, papG allele II, iha, iutA, sfaS, and fyuA) were epidemiologically associated with enhanced virulence, whereas nfaE was associ-ated with reduced virulence. Stratification of recurrent UTI isolates according to multiple same-strain recurrences, single same-strain recurrence, or isolated recurrence episode revealed potentially important virulence profile differences that otherwise were not apparent. E. coli phylogenetic group B2 and, in particular, its 2 constituent clonal groups that correspond with archetypal ExPEC strains 536 (pyelonephritis: O6:K53:H31) and RS218 (neonatal meningitis: O18:K1:H7) predominated in the study population and exhibited a markedly higher prevalence of most VFs than did other strains. The O18:K1 clonal group, in particular, exhibited enhanced virulence behavior. The extensive associations documented between VFs underscored the importance of cautious analysis and interpretation of molecular epidemiologic data and the need for experimental assessment of the contribution of specific putative VFs to the pathogenesis of extraintestinal E. coli infections.
